Clinical Trial Update: Peginterferon Beta-1a (BIIB017) Autoinjector Pharmacokinetic Study in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of the pegylated interferon beta-1a autoinjector (BIIB017) was conducted in healthy volunteers to assess its PK profile. The trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Peginterferon beta-1a (peginterferon beta-1a)

Snippet

Sponsor: Biogen | Conditions: Healthy, Multiple Sclerosis | Phase 1 | Status: COMPLETED